Woman and Man
- | Country : -
- | organs : -
- | Specialty : -
Extract
Primary Objectives •To estimate the 1-year (Week 52) probability of cumulative Major Cytogenetic Response (MCyR) in CP Ph+ CML patients with 1 or 2 prior lines of TKI therapy. •To estimate the 1-year (Week 52) probability of cumulative MCyR in CP Ph+ CML patients with 3 or more prior lines of TKI therapy. •To estimate the 1-year (Week 52) probability of cumulative confirmed Overall Hematological Response (OHR) in AP and BP Ph+ CML patients with any prior TKI therapy.
Inclusion criteria
- Philadelphia Chromosome Positive Chronic Myeloid Leukaemia